177 related articles for article (PubMed ID: 12627707)
21. Targeting telomerase.
Siddiqa A; Cavazos DA; Marciniak RA
Rejuvenation Res; 2006; 9(3):378-90. PubMed ID: 16859479
[TBL] [Abstract][Full Text] [Related]
22. Telomerase activity as a marker for malignancy in feline tissues.
Cadile CD; Kitchell BE; Biller BJ; Hetler ER; Balkin RG
Am J Vet Res; 2001 Oct; 62(10):1578-81. PubMed ID: 11592322
[TBL] [Abstract][Full Text] [Related]
23. Applications of telomerase research in the fight against cancer.
McKenzie KE; Umbricht CB; Sukumar S
Mol Med Today; 1999 Mar; 5(3):114-22. PubMed ID: 10203735
[TBL] [Abstract][Full Text] [Related]
24. The canine telomerase catalytic subunit (dogTERT): characterisation of the gene promoter and identification of proximal core sequences necessary for specific transcriptional activity in canine telomerase positive cell lines.
Long S; Argyle DJ; Gault EA; Campbell S; Nasir L
Gene; 2005 Sep; 358():111-20. PubMed ID: 16051448
[TBL] [Abstract][Full Text] [Related]
25. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
Babizhayev MA; Yegorov YE
J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
[TBL] [Abstract][Full Text] [Related]
26. Telomerase structure paves the way for new cancer therapies.
Skordalakes E
Future Oncol; 2009 Mar; 5(2):163-7. PubMed ID: 19284375
[TBL] [Abstract][Full Text] [Related]
27. Telomeres, telomerase and cancer: is the magic bullet real?
Sharma HW; Maltese JY; Zhu X; Kaiser HE; Narayanan R
Anticancer Res; 1996; 16(1):511-5. PubMed ID: 8615664
[TBL] [Abstract][Full Text] [Related]
28. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of canine telomerase in vitro and in vivo using RNAi: further development of a natural canine model for telomerase-based cancer therapies.
Lund JR; Paoloni M; Kurzman I; Padilla M; Argyle DJ
Vet J; 2008 Aug; 177(2):192-7. PubMed ID: 17981480
[TBL] [Abstract][Full Text] [Related]
30. Mouse models for telomere and telomerase biology.
Cheong C; Hong KU; Lee HW
Exp Mol Med; 2003 Jun; 35(3):141-53. PubMed ID: 12858012
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of an in vitro telomeric repeat amplification protocol assay to detect telomerase activity in canine urine.
McCleary-Wheeler AL; Williams LE; Hess PR; Suter SE
Am J Vet Res; 2010 Dec; 71(12):1468-74. PubMed ID: 21117999
[TBL] [Abstract][Full Text] [Related]
32. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas.
Nakayama J; Tahara H; Tahara E; Saito M; Ito K; Nakamura H; Nakanishi T; Tahara E; Ide T; Ishikawa F
Nat Genet; 1998 Jan; 18(1):65-8. PubMed ID: 9425903
[TBL] [Abstract][Full Text] [Related]
33. [Telomerase].
Ide T; Tahara H
Gan To Kagaku Ryoho; 1996 Feb; 23(3):247-56. PubMed ID: 8712815
[TBL] [Abstract][Full Text] [Related]
34. Telomere dynamics and telomerase activity in in vitro immortalised human cells.
Bryan TM; Reddel RR
Eur J Cancer; 1997 Apr; 33(5):767-73. PubMed ID: 9282115
[TBL] [Abstract][Full Text] [Related]
35. Proliferation characteristics of canine transmissible venereal tumor.
Chu RM; Lin CY; Liu CC; Yang SY; Hsiao YW; Hung SW; Pao HN; Liao KW
Anticancer Res; 2001; 21(6A):4017-24. PubMed ID: 11911286
[TBL] [Abstract][Full Text] [Related]
36. Targeting the telosome: therapeutic implications.
Folini M; Gandellini P; Zaffaroni N
Biochim Biophys Acta; 2009 Apr; 1792(4):309-16. PubMed ID: 19419699
[TBL] [Abstract][Full Text] [Related]
37. Determination of telomerase activity and telomere length.
Wu KD; Moore MA
Methods Mol Med; 2005; 113():207-23. PubMed ID: 15968105
[TBL] [Abstract][Full Text] [Related]
38. Canine paediatric oncology: retrospective assessment of 9522 tumours in dogs up to 12 months (1993-2008).
Schmidt JM; North SM; Freeman KP; Ramiro-Ibañez F
Vet Comp Oncol; 2010 Dec; 8(4):283-92. PubMed ID: 21062410
[TBL] [Abstract][Full Text] [Related]
39. Telomerase: is it the future diagnostic and prognostic tool in human cancer?
Mabruk MJ; O'Flatharta C
Expert Rev Mol Diagn; 2005 Nov; 5(6):907-16. PubMed ID: 16255632
[TBL] [Abstract][Full Text] [Related]
40. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway.
Kelland L
Clin Cancer Res; 2007 Sep; 13(17):4960-3. PubMed ID: 17785545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
